Pharmalot… Pharmalittle… The Weekend Nears
Make a commentBy Ed Silverman // July 30th, 2010 // 6:57 am
Hello, everyone, and top of the morning to you. ‘Tis a shiny day here on the Pharmalot corporate campus, where we look forward to a relaxing weekend of reading, walking our official Pharmalot mascots and frolicking with the shortest of short people. What about you? Any special plans? An afternoon at the beach? A night out with someone special? How about a good movie? Whatever you do, have a great time. Meanwhile, here are some tidbits. Stay in touch and see you soon…
Charles River Abandons Plan To Buy WuXi (Outsourcing Pharma)
Sanofi’s Viehbacher Tries To Cope (Associated Press)
Obese Patients Lose Weight On Orexigen Drug (Reuters)
Merck’s Dutch Employees Go To Court Over Job Cuts (Dow Jones)
Test Designed To Screen Resistance To Gleevec (Reuters)
FDA Finds Problems At Sanofi-Aventis Vaccine Plant (Reuters)
Drugmakers Give $5M In Rebates To NJ ADAP Program (Associated Press)
New Jersey’s Biotechs Still Growing (The Star-Ledger)
Wellcome Trust And India Form Affordable Meds Partnership (PharmaTimes)
Cody Labs To Halt Morphine Production (Billings Gazette)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
ADAP, Affordable Medicines, AIDS, Biotech, Charles River Laboratories, Chris Viehbacher, Cody Labs, Diagnostic Testing, Drug Rebates, Gleevec, India, jobs, Merck, Morphine, New Jersey, Novartis, Obesity, Orexigen, Sanofi Aventis, Wellcome Trust, WuXi